Back to Search Start Over

A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers

Authors :
Munir Pirmohamed
Guruprasad P. Aithal
Felix Stickel
Mark Thursz
David Goldman
Paul S. Haber
John Whitfield
Romain Moirand
Bertrand Nalpas
Devanshi Seth
Christophe Moreno
Andrew Thompson
Eric Trepo
Stephen R. Atkinson
Rebecca Darlay
Beat Müllhaupt
Timothy R. Morgan
Dermot Gleeson
Sylvie Naveau
Ann K. Daly
Helmut K. Seitz
Michael Soyka
Christopher P. Day
Tatiana Foroud
Jean-Marc Jacquet
Laura E. Nagy
Naga Chalasani
Pascal Perney
Philippe Mathurin
Marsha Y. Morgan
Pierre Nahon
Sebastian Mueller
Tiebing Liang
Florian Eyer
Suthat Liangpunsakul
Heather J. Cordell
Steven Masson
Tae-Hwi Schwantes-An
Ramon Bataller
Greg Botwin
Andrew McQuillin
QIMR Berghofer Medical Research Institute
Indiana University School of Medicine
Indiana University System
Newcastle University [Newcastle]
University of Nottingham, UK (UON)
Imperial College London
University of Pittsburgh Medical Center [Pittsburgh, PA, États-Unis] (UPMC)
California State University [Long Beach] (CSULB )
Indiana University - Purdue University Indianapolis (IUPUI)
Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institutes of Health [Bethesda] (NIH)
The University of Sydney
Hôpital Universitaire Carémeau [Nîmes] (CHU Nîmes)
Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)
Hôpital Claude Huriez [Lille]
CHU Lille
Nutrition, Métabolismes et Cancer (NuMeCan)
Université de Rennes 1 (UR1)
Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)
University College of London [London] (UCL)
Université libre de Bruxelles (ULB)
University of Heidelberg, Medical Faculty
University hospital of Zurich [Zurich]
Lerner Research Institute
Cleveland Clinic
Génomique Fonctionnelle des Tumeurs Solides (U1162)
Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
AP-HP - Hôpital Antoine Béclère [Clamart]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Centre de recherche en épidémiologie et santé des populations (CESP)
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay
University of Liverpool
University-Hospital Munich-Großhadern [München]
University of California
Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)
Lerner Research Institute [Cleveland, OH, USA]
University of California (UC)
Technical University of Munich (TUM)
Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Rennes 1 (UR1)
Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)
Source :
Journal of Hepatology, Journal of Hepatology, Elsevier, 2021, ⟨10.1016/j.jhep.2021.10.005⟩, Journal of Hepatology, 2022, 76 (2), pp.275-282. ⟨10.1016/j.jhep.2021.10.005⟩, Journal of hepatology, vol 76, iss 2, JOURNAL OF HEPATOLOGY, J Hepatol
Publication Year :
2021
Publisher :
HAL CCSD, 2021.

Abstract

International audience; BACKGROUND and AIMS: Only a minority of excess alcohol drinkers develop cirrhosis. We developed and evaluated risk stratification scores to identify those at highest risk. METHODS: Three cohorts (GenomALC-1: n=1690, GenomALC-2: n=3037, UK Biobank: relevant n=6898) with a history of heavy alcohol consumption (≥80 g/day (men), ≥50 g/day (women), for ≥10 years) were included. Cases were participants with alcohol-related cirrhosis. Controls had a history of similar alcohol consumption but no evidence of liver disease. Risk scores were computed from up to eight genetic loci identified previously as associated with alcohol-related cirrhosis and three clinical risk factors. Score performance for the stratification of alcohol-related cirrhosis risk was assessed and compared across the alcohol-related liver disease spectrum, including hepatocellular carcinoma (HCC). RESULTS: A combination of three single nucleotide polymorphisms (SNPs) (PNPLA3:rs738409, SUGP1-TM6SF2:rs10401969, HSD17B13:rs6834314) and diabetes status best discriminated for cirrhosis risk. The odds ratio (OR) and 95% confidence intervals (CI) for the extreme score quintiles (Q1-Q5) of the 3-SNP score, based on independent allelic effect size estimates, were 5.99 (4.18;8.60) (GenomALC-1); 2.81 (2.03;3.89) (GenomALC-2); and 3.10 (2.32;4.14) (UK Biobank). Patients with diabetes and high-risk score, compared to those without diabetes and a low-risk score, had ORs increased to 14.7 (7.69;28.1) (GenomALC-1) and 17.1 (11.3;25.7) (UK Biobank). Patients with cirrhosis and HCC had significantly higher mean risk scores than patients with cirrhosis alone (0.76±0.06 versus 0.61±0.02, p=0.007). Score performance was not significantly enhanced by information on additional genetic risk variants, body mass index or coffee consumption. CONCLUSIONS: A risk score based on three genetic risk variants and diabetes status can provide meaningful risk stratification for cirrhosis in excess drinkers, allowing earlier prevention planning including intensive intervention. LAY SUMMARY: Excessive chronic drinking leads to liver cirrhosis in some people, but so far there is no way to identify those at high risk of developing this debilitating disease. Our study has developed a genetic risk score (GRS) test that can identify patients at high risk and shows that the risk of cirrhosis is increased >10-fold with just two risk factors - diabetes and high GRS. Risk assessment using this test has potential for early and personalised management of this disease in high-risk patients.

Details

Language :
English
ISSN :
01688278 and 16000641
Database :
OpenAIRE
Journal :
Journal of Hepatology, Journal of Hepatology, Elsevier, 2021, ⟨10.1016/j.jhep.2021.10.005⟩, Journal of Hepatology, 2022, 76 (2), pp.275-282. ⟨10.1016/j.jhep.2021.10.005⟩, Journal of hepatology, vol 76, iss 2, JOURNAL OF HEPATOLOGY, J Hepatol
Accession number :
edsair.doi.dedup.....57ae266a174b57b9947b780fbef2d23d
Full Text :
https://doi.org/10.1016/j.jhep.2021.10.005⟩